Citations

Clear

1011 citation(s) found for "Barry, WT".

Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction
Sorimachi, Hidemi, Obokata, Masaru , Takahashi, Naoki , Reddy, Yogesh N.V. , Jain, C. Charles , Verbrugge, Frederik H. , Koepp, Katlyn E. , Khosla, Sundeep , Jensen, Michael D. , Borlaug, Barry A. , Jain, Christopher C, Khosla, Sundeep , Nishimura, Rick , Borlaug, Barry A , Obokata, Masaru , Verbrugge, Frederik H , Takahashi, Naoki

Mayo Clinic

European Heart Journal | September 22, 2020 | Volume: 42 | Issue: 16 | Pages: 1595-1605

10.1093/eurheartj/ehaa823 | PMID 33227126 Get It

Abstract Aims Central obesity is a major risk factor for heart failure with preserved ejection fraction (HFpEF), particularly in women, but the mechanisms remain unclear. We hypothesized that sex-specific differences in visceral adipose tissue (VAT) content would differentially relate to haemodynamic severity of HFpEF in women and men. Methods and results Abdominal computed tomography (CT) and invasive haemodynamic exercise testing were performed in 105 subjects with HFpEF (63 women) and 105 age-, sex-, and body mass index-matched controls. Visceral adipose tissue area was quantified by CT. As compared with control women, VAT area was 34% higher in women with HFpEF (186 ± 112 vs. 139 ± 72 cm2, P = 0.006), while VAT area was not significantly different in men with or without HFpEF (294 ± 158 vs. 252 ± 92 cm2, P = 0.1). During exercise, pulmonary capillary wedge pressure (PCWP) increased markedly and to similar extent in both men and women with HFpEF. Women with increased VAT area displayed 33% higher PCWP during exercise compared with women with normal VAT area (28 ± 10 vs. 21 ± 10 mmHg, P = 0.001), whereas exercise PCWP was similar in men with or without excess VAT (24 ± 9 vs. 25 ± 6, P = 0.89). In women, each 100 cm2 increase in VAT area was associated with a 4.0 mmHg higher PCWP (95% CI 2.1, 6.0 mmHg; P < 0.0001), but there was no such relationship in men (interaction P = 0.009). Conclusions These data suggest that accumulation of excess VAT plays a distinct and important role in the pathophysiology of HFpEF preferentially in women. Further research is needed to better understand the mechanisms and treatment implications for visceral fat in HFpEF.
Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction
Ahmad, Ali , Toya, Takumi , Verbrugge, Frederik H. , Sara, Jaskanwal Deep Singh , Lerman, Lilach O. , Sara, Jaskanwal D, Toya, Takumi , Verbrugge, Frederik H , Corban, Michel , Borlaug, Barry A. , Lerman, Amir

Mayo Clinic

European Journal of Heart Failure | September 19, 2020 | Volume: 23 | Issue: 5 | Pages: 765-772

10.1002/ejhf.2010 | PMID 32949186 Get It

Aims This study uniquely explored the relationship between coronary microvascular function and exercise haemodynamics using concurrent invasive testing. Methods and results Fifty‐one consecutive patients with unexplained cardiac exertion symptoms, non‐obstructive coronary artery disease and normal left ventricular ejection fraction (>50%) underwent haemodynamic exercise assessment and concurrent coronary reactivity testing. Heart failure with preserved ejection fraction (HFpEF) was defined as a pulmonary arterial wedge pressure (PAWP) ≥15 mmHg at rest and/or ≥25 mmHg at peak exercise. Endothelium‐independent coronary microvascular dysfunction (CMD) was defined as a coronary flow reserve (CFR) ≤2.5, while endothelium‐dependent CMD was defined as ≤50% increase in coronary blood flow (CBF) in response to intracoronary acetylcholine infusions. Patients with HFpEF ( n = 22) had significantly lower CFR (2.5 ± 0.6 vs. 3.2 ± 0.7; P = 0.0003) and median %CBF increase in response to intracoronary acetylcholine [1 (−35; 34) vs. 64 (−4; 133); P = 0.002] compared to patients without HFpEF ( n = 29). PAWP was significantly higher in patients with endothelium‐independent CMD compared to controls during both rest and exercise. This significant elevation was only present during exercise in patients with endothelium‐dependent CMD compared to controls. CFR had significant inverse correlations with PAWP at rest (r = −0.31; P = 0.03) and peak exercise (r = −0.47, P = 0.001). CFR also had positive correlations with maximal exercise capacity (in W/kg) (r = 0.33, P = 0.02). Conclusions Coronary microvascular function is inversely associated with filling pressures, particularly during exercise. Both types of CMD are associated with higher filling pressures at peak exercise. These findings underscore the potential mechanism and therapeutic target for CMD and HFpEF.
Intraoperative management of a hybrid extracorporeal membrane oxygenation circuit for lung transplantation
Martin, Archer Kilbourne , Harrison, Barry, Fritz, Ashley Virginia , Landolfo, Kevin , Makey, Ian A., Sareyyüpoğlu, Başar , Brown, Thomas E. , Johnson, James L., Pham, Si M. , Thomas, Mathew , Thomas, Mathew , Harrison, Barry A, Landolfo, Kevin P, Thomas, Mathew , Pham, Si , Martin, Archer Kilbourne

Mayo Clinic

Journal of Cardiac Surgery | September 17, 2020 | Volume: 35 | Issue: 12 | Pages: 3560-3563

10.1111/jocs.15029 | PMID 32939826 Get It

Effects of exercise on thoracic blood volumes, lung fluid accumulation, and pulmonary diffusing capacity in heart failure with preserved ejection fraction
Fermoyle, Caitlin C. , Stewart, Glenn M. , Johnson, Bruce D. , Borlaug, Barry A.

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | September 16, 2020 | Volume: 319 | Issue: 5 | Pages: R602-R609

10.1152/ajpregu.00192.2020 | PMID 32936678 Get It

Patients with heart failure with preserved ejection fraction (HFpEF) experience symptoms of exertional dyspnea that may be related to lung fluid accumulation during exercise. A computed tomography (CT)-based method was used to measure exercise-induced changes in extravascular lung fluid content and thoracic blood volumes and to determine the effect of lung fluid on lung diffusing capacity for carbon monoxide (DLCO) in stable subjects with HFpEF and healthy controls. Nine subjects with HFpEF (age = 68 ± 8 yr; body mass index = 32.1 ± 2.6 kg/m2) and eight healthy controls (62 ± 9 yr, 23.8 ± 2.4 kg/m2) performed triplicate rebreathe DLCO/DLNO (lung diffusing capacity for nitric oxide) tests in a supine position at rest and duplicate measurements during two 5-min submaximal exercise stages (15W and 35W) and recovery. Subjects subsequently performed a 5-min exercise bout (35W) inside a CT scanner, and extravascular lung fluid content and thoracic blood volumes were quantified at rest and immediately following exercise from thoracic and contrast perfusion scans, respectively. Subjects with HFpEF had a higher lung fluid content at rest compared with controls (means ± SD, HFpEF: 14.4 ± 1.7%, control: 12.8 ± 1.7%, P = 0.043) and a higher lung fluid content following exercise (15.2 ± 2.0% vs. 12.6 ± 1.5%, P = 0.009). Higher lung fluid content was associated with a lower DLCO and alveolar-capillary membrane conductance (Dm) in subjects with HFpEF (DLCO: R = −0.57, P = 0.022, Dm: R = −0.61, P = 0.012) but not in controls. Pulmonary blood volume was not altered by exercise and was similar between groups. Submaximal exercise elicited a greater accumulation of lung fluid in subjects with HFpEF compared with in controls, and lung fluid content was negatively correlated with lung diffusing capacity and alveolar-capillary membrane conductance in subjects with HFpEF.
Altered Hemodynamics and End-Organ Damage in Heart Failure
Verbrugge, Frederik H. , Testani, Jeffrey M. , Borlaug, Barry A. , Borlaug, Barry A , Testani, Jeffrey M , Verbrugge, Frederik H , Guazzi, Marco

Mayo Clinic

Circulation | September 8, 2020 | Volume: 142 | Issue: 10 | Pages: 998-1012

10.1161/circulationaha.119.045409 | PMID 32897746 Get It

Heart failure is characterized by pathologic hemodynamic derangements, including elevated cardiac filling pressures (“backward” failure), which may or may not coexist with reduced cardiac output (“forward” failure). Even when normal during unstressed conditions such as rest, hemodynamics classically become abnormal during stressors such as exercise in patients with heart failure. This has important upstream and downstream effects on multiple organ systems, particularly with respect to the lungs and kidneys. Hemodynamic abnormalities in heart failure are affected by processes that extend well beyond the cardiac myocyte, including important roles for pericardial constraint, ventricular interaction, and altered venous capacity. Hemodynamic perturbations have widespread effects across multiple heart failure phenotypes, ranging from reduced to preserved ejection fraction, acute to chronic disease, and cardiogenic shock to preserved perfusion states. In the lung, hemodynamic derangements lead to the development of abnormalities in ventilatory control and efficiency, pulmonary congestion, capillary stress failure, and eventually pulmonary vascular disease. In the kidney, hemodynamic perturbations lead to sodium and water retention and worsening renal function. Improved understanding of the mechanisms by which altered hemodynamics in heart failure affect the lungs and kidneys is needed in order to design novel strategies to improve clinical outcomes.
Every Now and Then I Fall Apart
Jain, C. Charles , Egbe, Alexander C. , Borlaug, Barry A. , Borlaug, Barry A

Mayo Clinic

Circulation: Heart Failure | September 8, 2020 | Volume: 13 | Issue: 10 | Pages: No page available

10.1161/circheartfailure.120.007145 | PMID 32894984 Get It

Locomotor muscle group III/IV afferents constrain stroke volume and contribute to exercise intolerance in human heart failure
Smith, Joshua R. , Joyner, Michael J. , Curry, Timothy B. , Borlaug, Barry A. , Keller‐Ross, Manda L. , Iterson, Erik H. Van , Olson, Thomas P. , Van Iterson, Erik H , Smith, Joshua R , Borlaug, Barry A , Joyner, Michael J , Keller-Ross, Manda

Mayo Clinic

The Journal of Physiology | September 4, 2020 | Volume: 598 | Issue: 23 | Pages: 5379-5390

10.1113/jp280333 | PMID 32886795 Get It

Key points Heart failure patients with reduced ejection fraction (HFrEF) exhibit severe limitations in exercise capacity ( peak). One of the primary peripheral mechanisms suggested to underlie exercise intolerance in HFrEF is excessive locomotor muscle group III/IV afferent feedback; however, this has never been investigated in human heart failure. HFrEF patients and controls performed an incremental exercise test to volitional exhaustion to determine peak with lumbar intrathecal fentanyl or placebo. During exercise, cardiac output, leg blood flow and radial artery and femoral venous blood gases were measured. With fentanyl, compared with placebo, patients with HFrEF achieved a higher peak workload, peak, cardiac output, stroke volume and leg blood flow. These findings suggest that locomotor muscle group III/IV afferent feedback in HFrEF leads to increased systemic vascular resistance, which constrains stroke volume, cardiac output and O2 delivery thereby impairing peak and thus exercise capacity. AbstractTo better understand the underlying mechanisms contributing to exercise limitation in heart failure with reduced ejection fraction (HFrEF), we investigated the influence of locomotor muscle group III/IV afferent inhibition via lumbar intrathecal fentanyl on peak exercise capacity ( peak) and the contributory mechanisms. Eleven HFrEF patients and eight healthy matched controls were recruited. The participants performed an incremental exercise test to volitional exhaustion to determine peak with lumbar intrathecal fentanyl or placebo. During exercise, cardiac output and leg blood flow () were measured via open‐circuit acetylene wash‐in technique and constant infusion thermodilution, respectively. Radial artery and femoral venous blood gases were measured. peak was 15% greater with fentanyl compared with placebo for HFrEF (P < 0.01), while no different in the controls. During peak exercise with fentanyl, cardiac output was 12% greater in HFrEF secondary to significant decreases in systemic vascular resistance and increases in stroke volume compared with placebo (all, P < 0.01). From placebo to fentanyl, leg , and O2 delivery were greater for HFrEF during peak exercise (all, P < 0.01), but not control. These findings indicate that locomotor muscle group III/IV afferent feedback in patients with HFrEF leads to increased systemic vascular resistance, which constrains stroke volume, cardiac output and O2 delivery, thereby impairing peak and thus exercise capacity. These findings have important clinical implications as peak is highly predictive of morbidity and mortality in HF.
Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophtha
Singer, Michael C. , Marchal, Francis, Bernet, Vic, Boucai, Laura , Buchholzer, Samanta , Burkey, Brian B., Eisele, David W. , Faure, Fréderic , Freitag, Suzanne K. , Gillespie, M. Boyd , Harrell, R. Mack, Hartl, Dana M. , Haymart, Megan R. , Leffert, Jonathan, Mandel, Susan J., Miller, Barbra S. , Pearce, Elizabeth N. , Rahmati, Rahmatullah, Ryan, William R. , Schaitkin, Barry M., Schlumberger, Martin, Stack, Brendan C. , Nostrand, Doug Van, Wong, Ka Kit , Stack, Brendan C , Pearce, Elizabeth N , Angelos, Peter , Bernet, Victor , Buchholzer, Samanta , Erkul, Evren , Morris, John, Nostrand, Douglas Van , Randolph, Gregory William

Mayo Clinic

Head & Neck | August 26, 2020 | Volume: 42 | Issue: 11 | Pages: 3446-3459

10.1002/hed.26417 | PMID 32812307 Get It

AbstractBackgroundPostoperative radioactive iodine (RAI) administration is widely utilized in patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to recognize the potential negative sequelae of this treatment. The prevention, diagnosis, and management of the salivary and lacrimal complications of RAI exposure are addressed in this consensus statement.MethodsA multidisciplinary panel of experts was convened under the auspices of the American Head and Neck Society Endocrine Surgery and Salivary Gland Sections. Following a comprehensive literature review to assess the current best evidence, this group developed six relevant consensus recommendations.ResultsConsensus recommendations on RAI were made in the areas of patient assessment, optimal utilization, complication prevention, and complication management.ConclusionSalivary and lacrimal complications secondary to RAI exposure are common and need to be weighed when considering its use. The recommendations included in this statement provide direction for approaches to minimize and manage these complications.
The multi-institutional myeloma group clinico-genomic risk stratification system: A blinded validation
Anguiano, A., Barry, William T., Gasparetto, Cristina, Shaughnessy, John D. , Potti, A., Tuchman, Sascha Alexander , Chng, Wee Joo , Zhan, Fenghuang , Gasparetto, Cristina , Fonseca, Rafaël

Mayo Clinic

Journal of Clinical Oncology | August 25, 2020 | Volume: 27 | Issue: 15_suppl | Pages: 8521-8521

10.1200/jco.2009.27.15_suppl.8521 Get It

8521 Background: Several clinical and molecular prognostic factors (e.g, International Staging System [ISS] stage, plasma cell labeling index, genomic models) exist for multiple myeloma (MM). We hypothesized that exploiting gene signatures representative of oncogenic pathway deregulation (i.e., Ras, Myc, etc.), would improve MM prognostication and also aid with the identification of novel therapeutic targets. Methods: Using a discovery cohort (n=47) of patients with MM and corresponding gene expression data, we built upon current molecular risk-stratification and devised a Bayesian genomic (“metagene”) model for prognosis. We validated that model in an independent patient cohort (n=207). Finally, we incorporated ISS staging and clinical variables to construct a combined Clinico-Genomic Risk Stratification System. We further validated the combined model in a separate cohort (n=72), in a blinded manner. Results: Using gene signatures predictive of oncogenic pathway activation in the discovery cohort, we identified specific patterns (metagenes) of signaling pathway activation with prognostic relevance. In an independent validation cohort, this metagene-based model accurately predicted event free survival (EFS) independently of ISS (multivariate hazard ratio [HR] 3.4 for ISS stage, and 5.4 for the metagene model, p=0.002). Using multivariate risk modeling, we incorporated ISS staging and the metagene model into a Clinico-Genomic System and successfully stratified the validation cohort into three groups (low, intermediate, and high risk) with markedly different EFS (HR 4.2 for intermediate risk and 14.0 for high risk vs. the low risk cohort, p<0.0001). In an additional blinded validation, the Clinico-Genomic System again accurately predicted median overall survival (68.7 [low risk] vs 24.7 [intermediate risk] vs 18.7 months [high risk], p<0.0001); more accurately than either ISS or other reported genomic models. Conclusions: A combined Clinico-Genomic Risk Stratification System, building on patterns of oncogenic pathway activation and ISS staging system, improves upon current prognostic models in MM and identifies novel pathway targets for future therapeutic consideration. No significant financial relationships to disclose.
A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile
Matchett, William E. , Anguiano-Zarate, Stephanie S., Malewana, Goda Baddage Rakitha , Mudrick, Haley , Weldy, Melissa, Evert, Clayton , Khoruts, Alexander , Sadowsky, Michael J. , Barry, Michael A. , Anguiano-Zarate, Stephanie, Barry, Michael A

Mayo Clinic

Vaccines | August 23, 2020 | Volume: 8 | Issue: 3 | Pages: 470

10.3390/vaccines8030470 | PMID 32842679 Get It

Clostridium difficile causes nearly 500,000 infections and nearly 30,000 deaths each year in the U.S., which is estimated to cost $4.8 billion. C. difficile infection (CDI) arises from bacteria colonizing the large intestine and releasing two toxins, toxin A (TcdA) and toxin B (TcdB). Generating humoral immunity against C. difficile’s toxins provides protection against primary infection and recurrence. Thus, a vaccine may offer the best opportunity for sustained, long-term protection. We developed a novel single-cycle adenovirus (SC-Ad) vaccine against C. difficile expressing the receptor-binding domains from TcdA and TcdB. The single immunization of mice generated sustained toxin-binding antibody responses and protected them from lethal toxin challenge for up to 38 weeks. Immunized Syrian hamsters produced significant toxin-neutralizing antibodies that increased over 36 weeks. Single intramuscular immunization provided complete protection against lethal BI/NAP1/027 spore challenge 45 weeks later. These data suggest that this replicating vaccine may prove useful against CDI in humans.